Roles of VEGF-C and Smad4 in the Lymphangiogenesis, Lymphatic Metastasis, and Prognosis in Colon Cancer

Background/AimsWe combined two different signal pathways on transforming growth factor β1 (TGF-β1)-Smad and vascular endothelial growth factor C (VEGF-C)/VEGF receptors for exploring changes in pathway members and their influence on lymphangiogenesis and clinicopathological features.Materials and MethodsExpression of TGF-β1, TGF-βRII, Smad4, VEGF-C, and VEGFR-3 was immunohistochemically evaluated in 147 colon cancer patients who were followed up for 5 years.ResultsLymphatic vessel density in colon cancer tissues was significantly higher than in normal colonic tissues. Smad4 expression negatively correlated with lymphatic vessel count and VEGF-C expression. VEGF-C expression positively correlated with lymphatic vessel count. Analysis using the Kaplan–Meier method indicated that patients with VEGF-C-positive tumors had significantly shorter overall survival and tumor-free survival time than those with VEGF-C-negative tumors. Patients with Smad4-negative tumors had significantly shorter overall survival and tumor-free survival time than those with Smad4-positive tumors.ConclusionsBoth Smad4 and VEGF-C are involved in lymphangiogenesis and lymphatic metastasis. Smad4 and VEGF-C expression may be clinically useful indicators for prognostic evaluation in colon cancer patients.

[1]  B. Mehrara,et al.  TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. , 2008, American journal of physiology. Heart and circulatory physiology.

[2]  Bixiang Zhang,et al.  Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer. , 2009, Cancer letters.

[3]  Xin-chuan Chen,et al.  Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications , 2011, Journal of experimental & clinical cancer research : CR.

[4]  Giovanni Parmigiani,et al.  SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer , 2009, Clinical Cancer Research.

[5]  H. Tanke,et al.  Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients , 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[6]  Fei Su,et al.  Lymphangiogenesis and Its Relationship With Lymphatic Metastasis and Prognosis in Malignant Melanoma , 2008, Anatomical record.

[7]  S. Kumar,et al.  Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[8]  Xiao-wen He,et al.  Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice. , 2008, Chinese medical journal.

[9]  K. Ohba,et al.  Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -D , 2006, Clinical Cancer Research.

[10]  M. Feith,et al.  VEGF-C Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus , 2007, World Journal of Surgery.

[11]  L. Wang,et al.  Expression of DPC4/Smad4 in non-small-cell lung carcinoma and its relationship with angiogenesis. , 2008, Neoplasma (Bratislava).

[12]  Brian Bierie,et al.  Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer , 2006, Nature Reviews Cancer.

[13]  Yong-jig Cho,et al.  Antimetastatic role of Smad4 signaling in colorectal cancer. , 2010, Gastroenterology.

[14]  O. Volpert,et al.  Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Zhan,et al.  The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  M. Yashiro,et al.  Correlation Between Vascular Endothelial Growth Factor C Expression and Lymph Node Metastasis in T1 Carcinoma of the Colon and Rectum , 2003, Surgery Today.

[17]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[18]  Xi-mei Chen,et al.  Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases , 2010, BMC Cancer.

[19]  S. Cai,et al.  Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma. , 2008, World journal of gastroenterology.

[20]  L. Sui,et al.  The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer , 2012, Medical Oncology.

[21]  A. Roberts,et al.  Smad4-expression is decreased in breast cancer tissues: a retrospective study , 2006, BMC Cancer.

[22]  Thomas Hawighorst,et al.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.

[23]  J. Tímár,et al.  Lymphangiogenesis Correlates with Lymph Node Metastasis, Prognosis, and Angiogenic Phenotype in Human Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[24]  S. Nofech-Mozes,et al.  Lymphatic Vessel Density as a Prognostic Marker in Clinical Stage I Endocervical Adenocarcinoma , 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[25]  P. Liu,et al.  Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas. , 2009, Japanese journal of clinical oncology.

[26]  S. Fox,et al.  The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  C. Shields.  Intraocular Tumor-Associated Lymphangiogenesis: A Novel Prognostic Factor for Ciliary Body Melanomas with Extraocular Extension? , 2011 .

[28]  Karl H. Plate,et al.  From angiogenesis to lymphangiogenesis , 2001, Nature Medicine.

[29]  Hiroshi I. Suzuki,et al.  Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. , 2008, Blood.

[30]  Jukka-Pekka Mecklin,et al.  SMAD4 Levels and Response to 5-Fluorouracil in Colorectal Cancer , 2005, Clinical Cancer Research.

[31]  D. Royston,et al.  Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma , 2009, The Journal of pathology.

[32]  Lichun Li,et al.  Vascular Endothelial Growth Factor D and Intratumoral Lymphatics as Independent Prognostic Factors in Epithelial Ovarian Carcinoma , 2009, Anatomical record.

[33]  Takeo Iwama,et al.  Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.

[34]  Chen Chen,et al.  Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF. , 2010, BMB reports.

[35]  Yitao Jia,et al.  Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer. , 2004, World journal of gastroenterology.

[36]  G. Naumann,et al.  Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension? , 2010, Ophthalmology.